These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27603201)

  • 1. Using Molecular Initiating Events To Generate 2D Structure-Activity Relationships for Toxicity Screening.
    Allen TE; Liggi S; Goodman JM; Gutsell S; Russell PJ
    Chem Res Toxicol; 2016 Oct; 29(10):1611-1627. PubMed ID: 27603201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using 2D Structural Alerts to Define Chemical Categories for Molecular Initiating Events.
    Allen TEH; Goodman JM; Gutsell S; Russell PJ
    Toxicol Sci; 2018 Sep; 165(1):213-223. PubMed ID: 30020496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the use of in silico methods to predict the chemistry of molecular initiating events related to drug toxicity.
    Ellison CM; Enoch SJ; Cronin MT
    Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1481-95. PubMed ID: 22032332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Molecular Initiating Events to Develop a Structural Alert Based Screening Workflow for Nuclear Receptor Ligands Associated with Hepatic Steatosis.
    Mellor CL; Steinmetz FP; Cronin MT
    Chem Res Toxicol; 2016 Feb; 29(2):203-12. PubMed ID: 26787004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space.
    Shah F; Greene N
    Chem Res Toxicol; 2014 Jan; 27(1):86-98. PubMed ID: 24328225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization.
    Roberts DW; Patlewicz G; Kern PS; Gerberick F; Kimber I; Dearman RJ; Ryan CA; Basketter DA; Aptula AO
    Chem Res Toxicol; 2007 Jul; 20(7):1019-30. PubMed ID: 17555332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PASS Targets: Ligand-based multi-target computational system based on a public data and naïve Bayes approach.
    Pogodin PV; Lagunin AA; Filimonov DA; Poroikov VV
    SAR QSAR Environ Res; 2015; 26(10):783-93. PubMed ID: 26305108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematically evaluating read-across prediction and performance using a local validity approach characterized by chemical structure and bioactivity information.
    Shah I; Liu J; Judson RS; Thomas RS; Patlewicz G
    Regul Toxicol Pharmacol; 2016 Aug; 79():12-24. PubMed ID: 27174420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
    Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
    Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Guidance for In Vitro Androgen and Glucocorticoid Receptor ToxCast Assays.
    Allen TEH; Nelms MD; Edwards SW; Goodman JM; Gutsell S; Russell PJ
    Environ Sci Technol; 2020 Jun; 54(12):7461-7470. PubMed ID: 32432465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
    Valerio LG; Cross KP
    Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Database of bioactive ring systems with calculated properties and its use in bioisosteric design and scaffold hopping.
    Ertl P
    Bioorg Med Chem; 2012 Sep; 20(18):5436-42. PubMed ID: 22436390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Mechanistic Framework for Integrating Chemical Structure and High-Throughput Screening Results to Improve Toxicity Predictions.
    Nelms MD; Mellor CL; Enoch SJ; Judson RS; Patlewicz G; Richard AM; Madden JM; Cronin MTD; Edwards SW
    Comput Toxicol; 2018 Nov; 8():1-12. PubMed ID: 36779220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BioProfile--extract knowledge from corporate databases to assess cross-reactivities of compounds.
    Beck B
    Bioorg Med Chem; 2012 Sep; 20(18):5428-35. PubMed ID: 22633121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Alerts and Random Forest Models in a Consensus Approach for Receptor Binding Molecular Initiating Events.
    Wedlake AJ; Folia M; Piechota S; Allen TEH; Goodman JM; Gutsell S; Russell PJ
    Chem Res Toxicol; 2020 Feb; 33(2):388-401. PubMed ID: 31850746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules.
    Luker T; Alcaraz L; Chohan KK; Blomberg N; Brown DS; Butlin RJ; Elebring T; Griffin AM; Guile S; St-Gallay S; Swahn BM; Swallow S; Waring MJ; Wenlock MC; Leeson PD
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5673-9. PubMed ID: 21852131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges for computational structure-activity modelling for predicting chemical toxicity: future improvements?
    Combes RD
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1129-40. PubMed ID: 21756202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of drug targets related to the induction of ventricular tachyarrhythmia through a systems chemical biology approach.
    Ivanov SM; Lagunin AA; Pogodin PV; Filimonov DA; Poroikov VV
    Toxicol Sci; 2015 Jun; 145(2):321-36. PubMed ID: 25766883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capturing structure-activity relationships from chemogenomic spaces.
    Wendt B; Uhrig U; Bös F
    J Chem Inf Model; 2011 Apr; 51(4):843-51. PubMed ID: 21410249
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.